- July 15, 2017
- Posted by: Neil Wilkie
- Category: Uncategorized
Mironid is delighted to announce the appointment of Dr Mark Holbrook PhD as their Safety Pharmacology consultant.
Prior to setting up VAST Pharma Solutions in 2016, Dr Holbrook held the dual role of VP Chief Scientific Officer for Early Development and Head of Global Safety Pharmacology at Covance. These roles allowed him to support integrated drug development from lead optimisation to the clinic through to proof of concept. Prior to that, Dr Holbrook was Head of Global Safety Pharmacology at Pfizer. In this role he led a team based on six sites across Europe, North America and Asia supporting the Pfizer global portfolio. Dr Holbrook has also previously held senior positions at Astra Zeneca and Celltech (UCB).